Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-01
2011-03-01
Royds, Leslie A. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S600000
Reexamination Certificate
active
07897636
ABSTRACT:
The present invention is directed to novel sulfamide derivatives, pharmaceutical compositions comprising said compounds and methods for the treatment of epilepsy and related disorders comprising administering to a subject in need thereof, said compounds, either alone or as co-therapy with one or more anticonvulsant and/or anti-epileptic agents.
REFERENCES:
patent: 2006/0047001 (2006-03-01), Parker et al.
patent: 2006/023861 (2006-03-01), None
patent: 2007/098486 (2007-08-01), None
Swinyard EA, Woodhead JH, White HS, Franklin MR. Experimental selection, quantification, and evaluation of anticonvulsants. In Levy RH, et al., eds.Antiepileptic Drugs. 3rded. New York: Raven Press, 1989:85-102.
Duggan et al., “Identification of the biologically active form of sulindac” Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, US, vol., 201, No, 1, 1977, pp. 8-13.
International Search Report re: PCT/US2008/072509 dated Nov. 5, 2008.
Breslav Michael
Klein Brian
Li Xun
Moyer John A.
Villani Frank J.
Janssen Pharmaceutica NV
Royds Leslie A.
LandOfFree
Sulfamide derivative useful for the treatment of epilepsy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfamide derivative useful for the treatment of epilepsy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfamide derivative useful for the treatment of epilepsy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2756483